PAX8 and thyroid cancer: Song et al. reviewed the studies involving the Asian population, which reported a much lower prevalence of PAX8/PPARγ in thyroid cancers than those from the Western populations (on average, 6% in FTC from Asian vs. 44% from American vs. 27% from European) [19].